GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen YHLO Biotech Co Ltd (SHSE:688575) » Definitions » EBITDA Margin %

Shenzhen YHLO Biotech Co (SHSE:688575) EBITDA Margin % : 12.01% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shenzhen YHLO Biotech Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shenzhen YHLO Biotech Co's EBITDA for the three months ended in Sep. 2024 was ¥52 Mil. Shenzhen YHLO Biotech Co's Revenue for the three months ended in Sep. 2024 was ¥434 Mil. Therefore, Shenzhen YHLO Biotech Co's EBITDA margin for the quarter that ended in Sep. 2024 was 12.01%.


Shenzhen YHLO Biotech Co EBITDA Margin % Historical Data

The historical data trend for Shenzhen YHLO Biotech Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen YHLO Biotech Co EBITDA Margin % Chart

Shenzhen YHLO Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 20.45 32.45 28.72 33.65 26.17

Shenzhen YHLO Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.30 11.62 14.99 21.15 12.01

Competitive Comparison of Shenzhen YHLO Biotech Co's EBITDA Margin %

For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen YHLO Biotech Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shenzhen YHLO Biotech Co's EBITDA Margin % falls into.



Shenzhen YHLO Biotech Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shenzhen YHLO Biotech Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=537.364/2053.101
=26.17 %

Shenzhen YHLO Biotech Co's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=52.096/433.826
=12.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen YHLO Biotech Co  (SHSE:688575) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Shenzhen YHLO Biotech Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Shenzhen YHLO Biotech Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen YHLO Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Baolong 2nd Road, Baolong Street, Building 1, Yahuilong Biological Technology Factory, Longgang District, Guangdong, Shenzhen, CHN, 518116
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
Executives
Xiao Yu Jin senior management
Liao Li Sheng Directors, senior managers
Pang Shi Hong senior management
Song Yong Bo Directors, senior managers
Hu Kun Hui Director
Xia Fu Zhen Core technical personnel

Shenzhen YHLO Biotech Co Headlines

No Headlines